Find a Commonwealth Resource
Ibrutinib
HealthData.Gov
Updated Mar 25, 2026
About this dataset
Imbruvica (ibrutinib) is an oral prescription medication that acts as a kinase inhibitor to help treat certain blood cancers. Available as tablets (140mg, 230mg, 420mg, 560mg), capsules (70mg, 140mg), and suspension (70mg/mL), it's manufactured by Pharmacyclics LLC. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Ibrutinib
Access the FDA dataset for Ibrutinib — ANDA 203308 submitted by Mylan Institutional LLC
Modified Mar 24, 2026